|
EP1309341A2
(en)
|
2000-07-07 |
2003-05-14 |
Lars Lannfelt |
Prevention and treatment of alzheimer's disease
|
|
WO2010012004A2
(en)
*
|
2008-07-25 |
2010-01-28 |
The Regents Of The University Of California |
Monoclonal antibodies specific for pathological amyoid aggregates common to amyloids formed from proteins of differing sequence
|
|
US20110200609A1
(en)
*
|
2002-09-12 |
2011-08-18 |
The Regents Of The University Of California |
Monoclonal antibodies specific for pathological amyloid aggregates common to amyloids formed from proteins of differing sequence
|
|
WO2010011999A2
(en)
*
|
2008-07-25 |
2010-01-28 |
The Regents Of The University Of California |
Methods and compositions for eliciting an amyloid-selective immune response
|
|
DE10303974A1
(de)
|
2003-01-31 |
2004-08-05 |
Abbott Gmbh & Co. Kg |
Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
|
|
SE0401601D0
(sv)
*
|
2004-06-21 |
2004-06-21 |
Bioarctic Neuroscience Ab |
Protofibril specific antibodies and uses thereof
|
|
WO2006014638A2
(en)
*
|
2004-07-19 |
2006-02-09 |
The General Hospital Corporation |
ANTIBODIES TO CROSS-LINKED AMYLOID β OLIGOMERS
|
|
BRPI0513959A
(pt)
|
2004-07-30 |
2008-05-20 |
Rinat Neuroscience Corp |
anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos
|
|
US7780963B2
(en)
|
2004-10-25 |
2010-08-24 |
Merck & Co., Inc. |
Anti-ADDL antibodies and uses thereof
|
|
US7731962B2
(en)
|
2005-02-14 |
2010-06-08 |
Merck & Co., Inc. |
Anti-ADDL monoclonal antibody and use thereof
|
|
US8420093B2
(en)
|
2005-02-14 |
2013-04-16 |
Merck Sharp & Dohme Corp. |
Anti-ADDL monoclonal antibody and use thereof
|
|
PE20061323A1
(es)
|
2005-04-29 |
2007-02-09 |
Rinat Neuroscience Corp |
Anticuerpos dirigidos contra el peptido amiloide beta y metodos que utilizan los mismos
|
|
EP3299027A1
(en)
*
|
2005-11-04 |
2018-03-28 |
Genentech, Inc. |
Use of complement pathway inhibitors to treat ocular diseases
|
|
PL2289909T3
(pl)
|
2005-11-30 |
2015-04-30 |
Abbvie Inc |
Sposób przeszukiwania, proces oczyszczania niedyfundujących oligomerów Abeta, selektywne przeciwciała przeciw niedyfundującym oligomerom Abeta i sposób wytwarzania tych przeciwciał
|
|
RU2432362C2
(ru)
|
2005-11-30 |
2011-10-27 |
Эбботт Лэборетриз |
Моноклональные антитела и их применения
|
|
SG10201404801YA
(en)
|
2005-12-12 |
2014-09-26 |
Ac Immune Sa |
Monoclonal antibody
|
|
RU2429244C2
(ru)
*
|
2006-03-23 |
2011-09-20 |
Байоарктик Ньюросайенс Аб |
Улучшенные селективные в отношении протофибрилл антитела и их применение
|
|
GB0611708D0
(en)
*
|
2006-06-14 |
2006-07-26 |
Common Services Agency |
Novel antibodies against prion protein and uses thereof
|
|
NZ574188A
(en)
*
|
2006-07-14 |
2012-05-25 |
Ac Immune Sa |
Humanized antibody against amyloid beta
|
|
DE602006005806D1
(de)
*
|
2006-07-28 |
2009-04-30 |
Vista Ventures Gmbh |
Verfahren zum Nachweis der amyloid-beta Oligomere in Körperflüssigkeiten
|
|
US8455626B2
(en)
*
|
2006-11-30 |
2013-06-04 |
Abbott Laboratories |
Aβ conformer selective anti-aβ globulomer monoclonal antibodies
|
|
WO2008143708A2
(en)
*
|
2006-12-07 |
2008-11-27 |
Mayo Foundation For Medical Education And Research |
Methods and materials related to anti-amyloid antibodies
|
|
JP2010515717A
(ja)
|
2007-01-11 |
2010-05-13 |
フィリップス−ウニベルジテート・マールブルク |
アルツハイマーおよび他の神経性認知症疾患の診断ならびに処置
|
|
EP2124952A2
(en)
|
2007-02-27 |
2009-12-02 |
Abbott GmbH & Co. KG |
Method for the treatment of amyloidoses
|
|
AU2008220785B2
(en)
|
2007-03-01 |
2013-02-21 |
Vivoryon Therapeutics N.V. |
New use of glutaminyl cyclase inhibitors
|
|
US20090022728A1
(en)
*
|
2007-03-09 |
2009-01-22 |
Rinat Neuroscience Corporation |
Methods of treating ophthalmic diseases
|
|
JP5667440B2
(ja)
|
2007-04-18 |
2015-02-12 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
|
|
US8613923B2
(en)
*
|
2007-06-12 |
2013-12-24 |
Ac Immune S.A. |
Monoclonal antibody
|
|
US8048420B2
(en)
*
|
2007-06-12 |
2011-11-01 |
Ac Immune S.A. |
Monoclonal antibody
|
|
PL2170389T3
(pl)
*
|
2007-06-12 |
2015-03-31 |
Ac Immune Sa |
Humanizowane przeciwciało przeciw amyloidowi beta
|
|
SG178809A1
(en)
*
|
2007-10-05 |
2012-03-29 |
Genentech Inc |
Use of anti-amyloid beta antibody in ocular diseases
|
|
RS53174B
(sr)
*
|
2007-10-05 |
2014-06-30 |
Genentech Inc. |
Upotreba antiamiloidnog beta antitela u slučaju oboljenja oka
|
|
DK2207568T3
(en)
*
|
2007-11-16 |
2017-09-18 |
Univ Rockefeller |
ANTIBODIES SPECIFIC TO THE PROTOFIBRILE FORM OF BETA AMYLOID PROTEIN
|
|
DK2237803T3
(en)
*
|
2007-12-28 |
2015-10-05 |
Prothena Biosciences Ltd |
Treatment and prophylaxis of amyloidosis
|
|
US8614297B2
(en)
|
2008-12-22 |
2013-12-24 |
Hoffmann-La Roche Inc. |
Anti-idiotype antibody against an antibody against the amyloid β peptide
|
|
US8409584B2
(en)
|
2009-05-05 |
2013-04-02 |
New York University |
Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins
|
|
JP5934645B2
(ja)
|
2009-09-11 |
2016-06-15 |
プロビオドルグ エージー |
グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
|
|
WO2011107530A2
(en)
|
2010-03-03 |
2011-09-09 |
Probiodrug Ag |
Novel inhibitors
|
|
JP5688745B2
(ja)
|
2010-03-10 |
2015-03-25 |
プロビオドルグ エージー |
グルタミニルシクラーゼ（ｑｃ、ｅｃ２．３．２．５）の複素環阻害剤
|
|
ES2684475T3
(es)
|
2010-04-15 |
2018-10-03 |
Abbvie Inc. |
Proteínas que se unen a beta amiloide
|
|
WO2011131748A2
(en)
|
2010-04-21 |
2011-10-27 |
Probiodrug Ag |
Novel inhibitors
|
|
RU2607368C2
(ru)
|
2010-07-30 |
2017-01-10 |
Ац Иммуне С.А. |
Безопасные и функциональные гуманизированные антитела
|
|
CN103298833B
(zh)
|
2010-08-14 |
2015-12-16 |
Abbvie公司 |
β淀粉样蛋白结合蛋白
|
|
EP2686313B1
(en)
|
2011-03-16 |
2016-02-03 |
Probiodrug AG |
Benzimidazole derivatives as inhibitors of glutaminyl cyclase
|
|
GB201113570D0
(en)
*
|
2011-08-05 |
2011-09-21 |
Glaxosmithkline Biolog Sa |
Vaccine
|
|
JP2013159596A
(ja)
*
|
2012-02-08 |
2013-08-19 |
Nihon Univ |
β−アミロイド前駆体タンパク質のマイクロ凝集体に特異的なモノクローナル抗体
|
|
EP3166970B1
(en)
|
2014-07-10 |
2021-03-10 |
BioArctic AB |
Improved a-beta protofibril binding antibodies
|
|
US10633433B2
(en)
|
2015-01-28 |
2020-04-28 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
|
US9879080B2
(en)
|
2015-01-28 |
2018-01-30 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
|
US10464999B2
(en)
|
2015-01-28 |
2019-11-05 |
Prothena Biosciences Limited |
Anti-transthyretin antibodies
|
|
CA3004494A1
(en)
|
2015-11-09 |
2017-05-18 |
The University Of British Columiba |
Epitopes in amyloid beta mid-region and conformationally-selective antibodies thereto
|
|
US10772969B2
(en)
|
2015-11-09 |
2020-09-15 |
The University Of British Columbia |
N-terminal epitopes in amyloid beta and conformationally-selective antibodies thereto
|
|
US10759837B2
(en)
|
2015-11-09 |
2020-09-01 |
The University Of British Columbia |
Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
|
|
CN109476729A
(zh)
|
2016-07-18 |
2019-03-15 |
英属哥伦比亚大学 |
淀粉样蛋白β的抗体
|
|
WO2018018031A1
(en)
*
|
2016-07-22 |
2018-01-25 |
New York University |
Specific murine and humanized monoclonal antibodies detecting pathology associated secondary structure changes in proteins and peptides
|
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
|
US12286469B2
(en)
|
2017-07-18 |
2025-04-29 |
The University Of British Columbia |
Humanized antibodies binding to amyloid-beta (A-beta)
|
|
ES2812698T3
(es)
|
2017-09-29 |
2021-03-18 |
Probiodrug Ag |
Inhibidores de glutaminil ciclasa
|
|
CU24731B1
(es)
|
2017-10-06 |
2025-01-15 |
Prothena Biosciences Ltd |
Anticuerpos anti-transtiretina
|
|
CN111757730A
(zh)
|
2017-10-06 |
2020-10-09 |
普罗塞纳生物科学有限公司 |
检测甲状腺素运载蛋白的方法
|
|
CU20200042A7
(es)
|
2017-11-29 |
2021-03-11 |
Prothena Biosciences Ltd |
Formulación liofilizada de un anticuerpo monoclonal contra la transtirretina
|
|
US20220260593A1
(en)
*
|
2019-06-13 |
2022-08-18 |
Michael Sierks |
Targets and methods of diagnosing, monitoring and treating frontotemporal dementia
|
|
CN113308439B
(zh)
*
|
2020-11-06 |
2023-05-05 |
华中科技大学 |
分泌人淀粉样蛋白-β单克隆抗体的杂交瘤细胞株及其应用
|